June 14 (Reuters) - The U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain with the updated shots, if feasible, changing its earlier advisory seeking targeting of the JN.1 variant, which was dominant earlier this year. (Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar)